Incorrect data

Incorrect data

Coronavirus - pandemic or not? They found that the R-naught value was approximately 2.2, which means about 2 persons can get ill from every contaminated person, making it more than infectious than the seasonal flu and the 1918 Spanish flu pandemic, with an R-naught value of 1, killed more than 50 million across the globe. To compare, the R-naught value of the SARS outbreak in 2003 has a value of 2 to 5. The Ebola disease has a value of 1.51 to 2.53, H1N1 has 1.48, MERS-CoV has 1, Smallpox has 5 to 7, and the most infectious of them all is measles with 12 to 18. Based on the data, there is evidence that human-to-human transmission has occurred among close contacts since December when the first cases were reported. “Considerable efforts to reduce transmission will be required to control outbreaks if similar dynamics apply elsewhere. Measures to prevent or reduce transmission should be implemented in populations at risk,” the researchers noted on the paper. Precautionary measures to prevent the spread of the virus is crucial. The WHO and the Centers for Disease Control and Prevention (CDC) recommends everyone to practice regular handwashing to prevent the spread of the virus. Further, everyone is urged to avoid crowded places, wear a mask or stay at home when sick, and seek medical attention when symptoms appear. New diagnostic test for coronavirus With the thousands of people being infected by the virus, diagnostic kit supplies are lacking. Countries are developing diagnostic tests to accommodate the testing of persons under investigation for the coronavirus infection. The U.S. Food and Drug Administration (FDA) issued an emergency approval of a test for the new coronavirus . It allows the new test to be performed in state health laboratories, in the aim to speed up efforts to detect cases of the virus in the United States. The FDA says that supplying and distributing the diagnostic test to qualified laboratories is a crucial step to protect public health and contain the spread of the virus. The regulatory agency approved the test under an Emergency Use Authorization to sidestep the usually regulatory channels. This will hasten the approval and distribution of the test kits when no other approved alternatives are available. The same method happened in approving test kits for other disease outbreaks, such as the Zika virus, Ebola virus, and the MERS-CoV. In the United States, about 260 people are under investigation for the infection. So far, 11 have been confirmed to harbor the virus, and 167 have been tested negative. The remaining 82 patients are still waiting for test results. Race to determine an effective treatment regimen Many countries are racing to find an effective treatment regimen to fight the virus. Various personalities and organizations are chipping in to find a cure for the illness and prevent further spread. Bill and Medline Gates are donating $100 million to coronavirus vaccine research and treatment efforts, which was declared as part of WHO’s request for $675 million in contributions worldwide. The funds will be used to assist the WHO and Chinese front-liners as they struggle to contain the deadly virus that has killed hundreds of people and infecting tens of thousands in mainland China and across the globe. Journal reference: Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K., Lau, E., Wong, J., Xing, X., and Xiang, N. et al. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia. The New England Journal of Medicine. https://www.nejm.org/doi/full/10.1056/NEJMoa2001316



Also in Industry News

How to decide whether or not to start treatment for prostate cancer?
How to decide whether or not to start treatment for prostate cancer?

0 Comments

How to decide whether or not to start treatment for prostate cancer?

Read More

Analysis of the SARS-CoV-2 proteome via visual tools
Analysis of the SARS-CoV-2 proteome via visual tools

0 Comments

Analysis of the SARS-CoV-2 proteome via visual tools

Read More

$65m investment increases British Patient Capital’s exposure to life sciences and health technology
$65m investment increases British Patient Capital’s exposure to life sciences and health technology

0 Comments

$65m investment increases British Patient Capital’s exposure to life sciences and health technology

Read More